AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32338720 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycled phototherapy (PT)
Number of subjects: 305
Study 33573341 — intervention group
Group type: EXPERIMENTAL
Intervention: iMBI plus treatment-as-usual
Number of subjects: 108
Study 33573341 — intervention group
Group type: COMPARATOR
Intervention: Enhanced treatment-as-usual
Number of subjects: 108
Study 32238176 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-help CBT intervention for voices (GiVE)
Number of subjects: 0
Study 32238176 — intervention group
Group type: COMPARATOR
Intervention: Supportive Counselling (SC)
Number of subjects: 0
Study 32238176 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study 35961614 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooking Matters for Diabetes intervention (6-week program with weekly food provision of 4 servings)
Number of subjects: 48
Study 35961614 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooking Matters for Diabetes intervention
Number of subjects: 48
Study 35961614 — intervention group
Group type: COMPARATOR
Intervention: Food insecure participants
Number of subjects: 48
Study 33993525 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate postoperative use of epinephrine
Number of subjects: 5773
Study 33993525 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate postoperative use of dobutamine
Number of subjects: 5773
Study 33993525 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrio-ventricular valve surgery
Number of subjects: 5773
Study 33993525 — intervention group
Group type: COMPARATOR
Intervention: Hypertension
Number of subjects: 5773
Study 35026880 — intervention group
Group type: EXPERIMENTAL
Intervention: Habb-e-Asab (250 mg twice a day for 45 days)
Number of subjects: 30
Study 35026880 — intervention group
Group type: COMPARATOR
Intervention: Placebo (250 mg twice a day for 45 days)
Number of subjects: 30
Study 33289256 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-month weight management programme
Number of subjects: 253
Study 33289256 — intervention group
Group type: COMPARATOR
Intervention: Usual diabetes care (Control)
Number of subjects: 253
Study 33289256 — intervention group
Group type: EXPERIMENTAL
Intervention: Ghrelin increase
Number of subjects: 253
Study 33289256 — intervention group
Group type: EXPERIMENTAL
Intervention: Ghrelin at 12 months
Number of subjects: 253
Study 33961310 — intervention group
Group type: EXPERIMENTAL
Intervention: Domagrozumab 5 mg/kg
Number of subjects: 19
Study 33961310 — intervention group
Group type: EXPERIMENTAL
Intervention: Domagrozumab 20 mg/kg
Number of subjects: 19
Study 33961310 — intervention group
Group type: EXPERIMENTAL
Intervention: Domagrozumab 40 mg/kg
Number of subjects: 19
Study 33961310 — intervention group
Group type: EXPERIMENTAL
Intervention: Domagrozumab (after switching from 5 mg/kg to 40 mg/kg)
Number of subjects: 19
Study 33961310 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 19
Study 33180565 — intervention group
Group type: EXPERIMENTAL
Intervention: SIFT IT group treatment program (14-week duration)
Number of subjects: 2
Study 36398695 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy plus corticosteroid injection (combined), single injection 3-6 days before physiotherapy
Number of subjects: 50
Study 36398695 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy alone
Number of subjects: 50
Study 34691078 — intervention group
Group type: EXPERIMENTAL
Intervention: N501Y mutation
Number of subjects: 0
Study 34691078 — intervention group
Group type: EXPERIMENTAL
Intervention: E484K mutation
Number of subjects: 0
Study 34691078 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined P.1 and B.1.351 RBD variants
Number of subjects: 0
Study 36384815 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Belief Model (HBM)‐based mobile messaging to adolescents and their parents for 24 weeks
Number of subjects: 12
Study 36384815 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Belief Model (HBM)‐based messaging to adolescents only for 24 weeks
Number of subjects: 12
Study 36384815 — intervention group
Group type: COMPARATOR
Intervention: Delivering e‐version of oral health education pamphlets to adolescents
Number of subjects: 12
Study 32197829 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5 mm anterior locking plate (LP)
Number of subjects: 16
Study 32197829 — intervention group
Group type: COMPARATOR
Intervention: Cannulated screws with anterior tension band wiring (hybrid osteosynthesis, HO)
Number of subjects: 16
Study 33346579 — intervention group
Group type: EXPERIMENTAL
Intervention: DGP-IgG
Number of subjects: 133
Study 33346579 — intervention group
Group type: COMPARATOR
Intervention: TTG-IgA
Number of subjects: 133
Study 33346579 — intervention group
Group type: EXPERIMENTAL
Intervention: DGP-IgG added to TTG-IgA
Number of subjects: 133
Study 33346579 — intervention group
Group type: EXPERIMENTAL
Intervention: DGP-IgG titer >2 times ULN
Number of subjects: 133
Study 33346579 — intervention group
Group type: EXPERIMENTAL
Intervention: DGP-IgG titer >4 times ULN
Number of subjects: 133
Study 33346579 — intervention group
Group type: EXPERIMENTAL
Intervention: TTG-IgA >10 times ULN in T1D patients
Number of subjects: 133
Study 32877578 — intervention group
Group type: EXPERIMENTAL
Intervention: IONIS-PKK-LRx administered at a dose of 80 mg every 3 to 4 weeks for 7 to 8 months after initial treatment with IONIS-PKKRx for 12 to 16 weeks.
Number of subjects: 2
Study 32877578 — intervention group
Group type: COMPARATOR
Intervention: IONIS-PKKRx administered weekly subcutaneous injections for 12 to 16 weeks.
Number of subjects: 2
Study 34979585 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet inflated from skin incision to cement hardening
Number of subjects: 90
Study 34979585 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet from cement application to hardening
Number of subjects: 90
Study 34979585 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet from skin incision to skin closure
Number of subjects: 90
Study 34979585 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 90
Study 33176129 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal high-flow (NHF) system at 2 kg/L/minute, up to a maximum of 30 L/minute
Number of subjects: 30
Study 33176129 — intervention group
Group type: COMPARATOR
Intervention: Nasal cannula (NC) group at 5 L/minute
Number of subjects: 30
Study 33176129 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal high-flow (NHF) system
Number of subjects: 30
Study 32459987 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory Support Intervention with multiple types of memory support strategies
Number of subjects: 428
Study 32459987 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory Support Intervention with one type of memory support strategy
Number of subjects: 428
Study 32459987 — intervention group
Group type: COMPARATOR
Intervention: Control intervention (no memory support)
Number of subjects: 428
Study 32459987 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory and learning of treatment contents
Number of subjects: 428
Study 35367003 — intervention group
Group type: EXPERIMENTAL
Intervention: ZyCoV-D vaccine (2 mg per dose, 3 doses administered intradermally via a needle-free injection system 28 days apart)
Number of subjects: 27703
Study 35367003 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 doses administered intradermally via a needle-free injection system 28 days apart)
Number of subjects: 27703
Study 35367003 — intervention group
Group type: EXPERIMENTAL
Intervention: ZyCoV-D vaccine
Number of subjects: 27703
Study 35367003 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27703
Study 34783725 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 600mg
Number of subjects: 50
Study 34783725 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol 1000mg
Number of subjects: 50
Study 32066412 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbiota-directed complementary food formulation (MDCF-2)
Number of subjects: 248
Study 32066412 — intervention group
Group type: COMPARATOR
Intervention: Conventional Ready-to-use Supplementary Food (RUSF)
Number of subjects: 248
Study 35565844 — intervention group
Group type: EXPERIMENTAL
Intervention: SAx (oral supplement containing Hydroxytyrosol and Punicalagin)
Number of subjects: 100
Study 35565844 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 34863109 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.1 μg/kg/hour)
Number of subjects: 60
Study 34863109 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34863109 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 34272791 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4742
Study 32725779 — intervention group
Group type: EXPERIMENTAL
Intervention: Image-guided radiotherapy (IGRT)
Number of subjects: 797
Study 32725779 — intervention group
Group type: COMPARATOR
Intervention: Non-image-guided radiotherapy (non-IGRT)
Number of subjects: 797
Study 36153600 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care ultrasound (POCUS)
Number of subjects: 244
Study 36153600 — intervention group
Group type: COMPARATOR
Intervention: Control group (no POCUS)
Number of subjects: 244
Study 36153600 — intervention group
Group type: EXPERIMENTAL
Intervention: POCUS
Number of subjects: 244
Study 33323224 — intervention group
Group type: EXPERIMENTAL
Intervention: Coach-supported internet intervention for self-management
Number of subjects: 2724
Study 33323224 — intervention group
Group type: COMPARATOR
Intervention: Control platform
Number of subjects: 2724
Study 35079831 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual lymph drainage (MLD) with progressive arm exercises; n=48
Number of subjects: 96
Study 35079831 — intervention group
Group type: COMPARATOR
Intervention: Standard arm exercises; n=48
Number of subjects: 96
Study 34367287 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenous bone mixed with bioactive glass (1:1 in volume)
Number of subjects: 0
Study 34367287 — intervention group
Group type: COMPARATOR
Intervention: Autogenous bone alone
Number of subjects: 0
Study 36383828 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-debriefing (intervention, n=9)
Number of subjects: 17
Study 36383828 — intervention group
Group type: COMPARATOR
Intervention: Debriefing with a facilitator (control, n=8)
Number of subjects: 17
Study 32929646 — intervention group
Group type: EXPERIMENTAL
Intervention: CSF Aβ42
Number of subjects: 314278
Study 32929646 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma amyloid species
Number of subjects: 314278
Study 32929646 — intervention group
Group type: EXPERIMENTAL
Intervention: CSF total tau
Number of subjects: 314278
Study 32929646 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphorylated tau181
Number of subjects: 314278
Study 32929646 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher genetically predicted plasma amyloid species, CSF total tau and phosphorylated tau181
Number of subjects: 314278
Study 32727496 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal injections of ranibizumab (0.5 mg) alone (IVOM-Group)
Number of subjects: 19
Study 32727496 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal injections of ranibizumab (0.5 mg) with additional micropulse diode laser (IVOM+Laser-Group)
Number of subjects: 19
Study 34596747 — intervention group
Group type: EXPERIMENTAL
Intervention: HUMI + (humidified warm gas with forced air warming blanket)
Number of subjects: 150
Study 34596747 — intervention group
Group type: EXPERIMENTAL
Intervention: HUMI (humidified warm gas without forced air warming blanket)
Number of subjects: 150
Study 34596747 — intervention group
Group type: COMPARATOR
Intervention: AIR (dry cold CO2 with forced air warming blanket)
Number of subjects: 150
Study 32803005 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated health promotion intervention (two sessions of 45 to 60 minutes Psychoeducational counseling, four telephone follow‐up support, and training pamphlets)
Number of subjects: 130
Study 32803005 — intervention group
Group type: COMPARATOR
Intervention: Routine education (Control group)
Number of subjects: 130
Study 32803005 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated health promotion intervention
Number of subjects: 130
Study 35037597 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin with nortriptyline
Number of subjects: 68
Study 35037597 — intervention group
Group type: COMPARATOR
Intervention: Placebo with nortriptyline
Number of subjects: 68
Study 34517869 — intervention group
Group type: EXPERIMENTAL
Intervention: Cogmed cognitive training (25 sessions over 5 to 8 weeks)
Number of subjects: 166
Study 34517869 — intervention group
Group type: COMPARATOR
Intervention: Standard care management (control group)
Number of subjects: 166
Study 32580074 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical cardioversion (ECV)
Number of subjects: 148
Study 32580074 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance of sinus rhythm (SR)
Number of subjects: 148
Study 32580074 — intervention group
Group type: EXPERIMENTAL
Intervention: AF relapse after successful ECV
Number of subjects: 148
Study 36413388 — intervention group
Group type: EXPERIMENTAL
Intervention: DiSCoVR (VR-SCT)
Number of subjects: 81
Study 36413388 — intervention group
Group type: COMPARATOR
Intervention: VRelax (active control)
Number of subjects: 81
Study 32900520 — intervention group
Group type: EXPERIMENTAL
Intervention: Stearic acid diet
Number of subjects: 34
Study 32085906 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention (ILI) to achieve/maintain 7% weight loss
Number of subjects: 5125
Study 32085906 — intervention group
Group type: COMPARATOR
Intervention: Standard Diabetes Support and Education (DSE)
Number of subjects: 5125
Study 33793972 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise test to exhaustion for cardiorespiratory fitness (CRF) assessment
Number of subjects: 37
Study 33793972 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerometer (Actigraph GT3X+) for estimating physical activity (PA)
Number of subjects: 37
Study 32361977 — intervention group
Group type: EXPERIMENTAL
Intervention: IMU‐838 (vidofludimus calcium) single doses (10-40 mg fasting, 10 mg fed)
Number of subjects: 64
Study 32361977 — intervention group
Group type: COMPARATOR
Intervention: IMU‐838 (vidofludimus calcium) multiple doses (30-50 mg)
Number of subjects: 64
Study 32361977 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in MAD study)
Number of subjects: 64
Study 33820455 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent aerobic exercise (cycling at 70% peak Watts)
Number of subjects: 12
Study 33820455 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 12
Study 33542279 — intervention group
Group type: EXPERIMENTAL
Intervention: 3‐nitrooxypropanol (3‐NOP), administered daily from birth until three weeks post‐weaning (week 14)
Number of subjects: 18
Study 33542279 — intervention group
Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 18
Study 32463430 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy (ATE)
Number of subjects: 60
Study 32463430 — intervention group
Group type: COMPARATOR
Intervention: Watchful Waiting
Number of subjects: 60
Study 35124707 — intervention group
Group type: EXPERIMENTAL
Intervention: P-PRP
Number of subjects: 610
Study 35124707 — intervention group
Group type: COMPARATOR
Intervention: Sham saline
Number of subjects: 610
Study 33775526 — intervention group
Group type: EXPERIMENTAL
Intervention: HOT conditions (∼50 °C, ∼35% relative humidity) at Tre of 39.5 °C
Number of subjects: 9
Study 33775526 — intervention group
Group type: EXPERIMENTAL
Intervention: HOT conditions (∼50 °C, ∼35% relative humidity) at Tre of 38.5 °C and 39.5 °C
Number of subjects: 9
Study 33775526 — intervention group
Group type: EXPERIMENTAL
Intervention: HOT conditions (∼50 °C, ∼35% relative humidity)
Number of subjects: 9
Study 33775526 — intervention group
Group type: COMPARATOR
Intervention: CON conditions (∼22 °C, ∼35% relative humidity) at Tre of ∼37 °C
Number of subjects: 9
Study 34686382 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender congruence and vignette modality (text, audio, video)
Number of subjects: 209
Study 34686382 — intervention group
Group type: COMPARATOR
Intervention: Vignette modality (video)
Number of subjects: 209
Study 33269608 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured intervention on self-care with AVF (SISC-AVF)
Number of subjects: 89
Study 32831109 — intervention group
Group type: EXPERIMENTAL
Intervention: Bang® Keto Coffee (130 kcal, 300 mg caffeine, 20 g protein)
Number of subjects: 16
Study 32831109 — intervention group
Group type: COMPARATOR
Intervention: Placebo (30 kcal, 11 mg caffeine, 1 g protein)
Number of subjects: 16
Study 33249320 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity resistance exercise (HIT‐RT) for 18 months
Number of subjects: 43
Study 33249320 — intervention group
Group type: COMPARATOR
Intervention: Non-training control group (CG)
Number of subjects: 43
Study 35040210 — intervention group
Group type: EXPERIMENTAL
Intervention: nano-curcumin 240 mg/day for 7 days
Number of subjects: 60
Study 35040210 — intervention group
Group type: EXPERIMENTAL
Intervention: nano-curcumin
Number of subjects: 60
Study 35040210 — intervention group
Group type: COMPARATOR
Intervention: control
Number of subjects: 60
Study 36092793 — intervention group
Group type: EXPERIMENTAL
Intervention: Multichannel CNN-based eye model
Number of subjects: 64
Study 36092793 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctors' experience and multichannel CNN-based eye model
Number of subjects: 64
Study 36092793 — intervention group
Group type: COMPARATOR
Intervention: Control group (Doctors' experience only)
Number of subjects: 64
Study 32995832 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-assisted ICSI (LA-ICSI)
Number of subjects: 966
Study 32995832 — intervention group
Group type: COMPARATOR
Intervention: Conventional ICSI
Number of subjects: 966
Study 35809488 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention (18 sessions over 12 months)
Number of subjects: 116
Study 35809488 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 116
Study 33473163 — intervention group
Group type: EXPERIMENTAL
Intervention: CTC-driven monitoring
Number of subjects: 204
Study 33473163 — intervention group
Group type: COMPARATOR
Intervention: Standard arm
Number of subjects: 204
Study 32380972 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth intervention with interactive features
Number of subjects: 0
Study 32380972 — intervention group
Group type: COMPARATOR
Intervention: eHealth intervention with static information
Number of subjects: 0
Study 35655213 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated breast massage (IBM)
Number of subjects: 84
Study 35655213 — intervention group
Group type: COMPARATOR
Intervention: Traditional breast massage (TBM)
Number of subjects: 84
Study 32442198 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anesthesia
Number of subjects: 197
Study 32442198 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous detachment
Number of subjects: 197
Study 32442198 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal slit requirement
Number of subjects: 197
Study 32442198 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall satisfaction
Number of subjects: 197
Study 615917691 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab (RBZ) 0.3 mg or 0.5 mg monthly injections
Number of subjects: 759
Study 615917691 — intervention group
Group type: COMPARATOR
Intervention: Sham injections
Number of subjects: 759
Study 33640493 — intervention group
Group type: EXPERIMENTAL
Intervention: Brolucizumab 6 mg
Number of subjects: 81
Study 35007113 — intervention group
Group type: EXPERIMENTAL
Intervention: State-funded pre-kindergarten program
Number of subjects: 2990
Study 35007113 — intervention group
Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 2990
Study 34323452 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical treatment
Number of subjects: 409
Study 34323452 — intervention group
Group type: COMPARATOR
Intervention: Surgical intervention
Number of subjects: 409
Study 35031340 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic ablative radiotherapy (SABR)
Number of subjects: 62
Study 35031340 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) treatment
Number of subjects: 62
Study 33447962 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe multiple symptoms
Number of subjects: 500
Study 33447962 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary incontinence
Number of subjects: 500
Study 34535938 — intervention group
Group type: EXPERIMENTAL
Intervention: EP-guided cryoballoon ablation (CBA)
Number of subjects: 136
Study 34535938 — intervention group
Group type: COMPARATOR
Intervention: Conventional cryoballoon ablation (CBA)
Number of subjects: 136
Study 33047942 — intervention group
Group type: EXPERIMENTAL
Intervention: LUCAS 3 mechanical CC device
Number of subjects: 67
Study 33047942 — intervention group
Group type: EXPERIMENTAL
Intervention: TrueCPR feedback device
Number of subjects: 67
Study 33047942 — intervention group
Group type: COMPARATOR
Intervention: Manual CCs
Number of subjects: 67
Study 35700341 — intervention group
Group type: EXPERIMENTAL
Intervention: E2027 (50 to 400 mg single doses)
Number of subjects: 164
Study 35700341 — intervention group
Group type: EXPERIMENTAL
Intervention: E2027 (≥50 mg QD)
Number of subjects: 164
Study 35700341 — intervention group
Group type: EXPERIMENTAL
Intervention: E2027 (50 mg QD)
Number of subjects: 164
Study 35700341 — intervention group
Group type: EXPERIMENTAL
Intervention: E2027 (single and multiple administration)
Number of subjects: 164
Study 34403019 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotic intervention designed to reduce hot flashes
Number of subjects: 0
Study 34403019 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study 34403019 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotic intervention
Number of subjects: 0
Study 35397233 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser blepharoplasty
Number of subjects: 145
Study 35397233 — intervention group
Group type: COMPARATOR
Intervention: Blade blepharoplasty
Number of subjects: 145
Study 33433656 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative oncology treatment program (high adherence, attending ≥4 sessions during the first 6 weeks)
Number of subjects: 815
Study 33433656 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative oncology treatment program (high adherence)
Number of subjects: 815